A Noncanonical MET Exon 14 Splice-Site Variant in Pulmonary Sarcomatoid Carcinoma With Response to Capmatinib.

Oh HJ, Choi YD, Choi YL, Park HY, Yoon JY, Kim JH, Lim JH, Park CK, Oh IJ, Kim YC

DOI: 10.1111/1759-7714.70371
Published: 2026 Aug
Container: Thoracic cancer
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/1759-7714.70371,
  title = {A Noncanonical MET Exon 14 Splice-Site Variant in Pulmonary Sarcomatoid Carcinoma With Response to Capmatinib.},
  author = {Oh HJ and Choi YD and Choi YL and Park HY and Yoon JY and Kim JH and Lim JH and Park CK and Oh IJ and Kim YC},
  year = {2026},
  journal = {Thoracic cancer},
  doi = {10.1111/1759-7714.70371},
  url = {https://doi.org/10.1111/1759-7714.70371}
}

RIS

TY  - JOUR
TI  - A Noncanonical MET Exon 14 Splice-Site Variant in Pulmonary Sarcomatoid Carcinoma With Response to Capmatinib.
AU  - Oh HJ
AU  - Choi YD
AU  - Choi YL
AU  - Park HY
AU  - Yoon JY
AU  - Kim JH
AU  - Lim JH
AU  - Park CK
AU  - Oh IJ
AU  - Kim YC
PY  - 2026
JO  - Thoracic cancer
DO  - 10.1111/1759-7714.70371
UR  - https://doi.org/10.1111/1759-7714.70371
ER  -

APA

HJ, O., YD, C., YL, C., HY, P., JY, Y., JH, K., JH, L., CK, P., IJ, O., & YC, K. (2026). A Noncanonical MET Exon 14 Splice-Site Variant in Pulmonary Sarcomatoid Carcinoma With Response to Capmatinib.. Thoracic cancer. https://doi.org/10.1111/1759-7714.70371

Source records

pubmed · retrieved 2026-09-27T08:50:58.079Z